Jeffrey Chamberlain, Ph.D.
Professor of Neurology, Biochemistry, and Medicine
Research Affiliate, Center on Human Development and Disability
University of Washington
Seattle, WA 98195-7720
Dr. Chamberlain researches the muscular dystrophies, primarily Duchenne muscular dystrophy (DMD), to develop a better understanding of the molecular basis of the pathophysiology of the diseases, and to develop gene and cell therapies to correct and treat them. DMD is the most common form of muscular dystrophy, affecting one in 3,500 newborn males, and is caused by mutations in the dystrophin gene. Chamberlain and his associates are studying the structure and function of the dystrophin gene, as well as developing viral vectors to deliver this or other genes to muscle cells for possible gene therapy.
Jeffrey Chamberlain's lab web page
University of Washington • Center on Human Development
and Disability Box 357920 • Seattle WA 98195-7920 USA • 206-543-7701
Copyright © 1996—2013 Center on Human Development and Disability. Updated:
November 16, 2011